Chembio Diagnostics

Chembio Diagnostics Rule of 40

Delisted

The Rule of 40 of Chembio Diagnostics (CEMI) as of Nov 18, 2026 is -11.38 %. In the previous year, Rule of 40 was -62.83 % — a change of -81.88% (higher).

Rule of 40

-11.38 %

YoY

-81.88%

Last updated:

Rule of 40 of Chembio Diagnostics is 2022 -11.38 % . Rule of 40 of Chembio Diagnostics was 2021 -62.83 % . It decreases by -81.88% higher compared to the previous year.

The Chembio Diagnostics Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2015
-26.91 USD
Jan 1, 2016
-68.70 USD
Jan 1, 2017
7.41 USD
Jan 1, 2018
16.23 USD
Jan 1, 2019
-35.52 USD
Jan 1, 2020
-87.62 USD
Jan 1, 2021
-62.83 USD
Jan 1, 2022
-11.38 USD
The Chembio Diagnostics Rule of 40 history
YEARRule of 40YoY
-11.38 %-81.88%
-62.83 %-28.29%
-87.62 %+146.70%
-35.52 %-318.80%
16.23 %+119.21%
7.41 %-110.78%
-68.70 %+155.27%
-26.91 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Chembio Diagnostics Stock analysis

What does Chembio Diagnostics do? Chembio Diagnostics Inc is a biomedical company specializing in the development and commercialization of diagnostic test kits. The company was founded in 1985 and is headquartered in Medford, New York. Chembio Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Chembio Diagnostics stock

Rule of 40 of Chembio Diagnostics is -11.38 % in 2022.

On Eulerpool you can find the complete historical development of Rule of 40 Chembio Diagnostics since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Chembio Diagnostics

All Key Metrics — Chembio Diagnostics